Scorpion Capital shorts TransMedics, alleging fraud in report
Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...
Scorpion Capital shorts TransMedics, shares down
Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...
BMO Capital markets settles with SEC over bond desk supervision
BMO Capital Markets agreed to pay more than $40 million to settle U.S. Securities and Exchange Commission charges it failed ...
TransMedics down 10% to $65.39 after Scorpion Capital short report
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
China's Simcere Pharma grants AbbVie option to license its blood cancer drug candidate
Simcere Pharmaceutical said on Monday its unit had granted U.S. drugmaker AbbVie the option to license its new blood cancer ...
TransMedics Group, Inc.: TransMedics Responds to Inaccurate and Misleading Claims in Recent ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...
AOL3 天
Why TransMedics Group Stock Is Tanking Today
The big sell-off came after activist short seller Scorpion Capital released a scathing report about TransMedics. Scorpion stated in its report, "TransMedics is the most extreme and grotesque ...
Mena FN3 天
Berman Tabacco Announces Investigation Of Transmedics Group, Inc. (TMDX) Concerning Claims ...
On January 10, 2025, Bloomberg reported TransMedics shares dropped“as much as 13% after Scorpion Capital said it is short the transplant-therapy company's stock.” ...